Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 46

1.

Comparison of Polycyclic Aromatic Hydrocarbons Exposure Across Occupations Using Urinary Metabolite 1-Hydroxypyrene.

Koh DH, Park JH, Lee SG, Kim HC, Choi S, Jung H, Park D.

Ann Work Expo Health. 2020 Feb 17. pii: wxaa014. doi: 10.1093/annweh/wxaa014. [Epub ahead of print]

PMID:
32064494
2.

Efficacy of pregabalin for the treatment of chronic pruritus of unknown origin, assessed based on electric current perception threshold.

Lee J, Jang D, Bae J, Jung H, Park M, Ahn J.

Sci Rep. 2020 Jan 23;10(1):1022. doi: 10.1038/s41598-020-57629-z.

3.

The oligomerization mediated by the alanine 397 residue in the transmembrane domain is crucial to sydecan-3 functions.

Jung H, Han M, Jang B, Park E, Oh ES.

Cell Signal. 2020 May;69:109544. doi: 10.1016/j.cellsig.2020.109544. Epub 2020 Jan 18.

PMID:
31962151
4.

D-tyrosine adds an anti-melanogenic effect to cosmetic peptides.

Park J, Jung H, Jang B, Song HK, Han IO, Oh ES.

Sci Rep. 2020 Jan 14;10(1):262. doi: 10.1038/s41598-019-57159-3.

5.

Transcriptome analysis to understand the effects of the toxoflavin and tropolone produced by phytopathogenic Burkholderia on Escherichia coli.

Park J, Lee HH, Jung H, Seo YS.

J Microbiol. 2019 Sep;57(9):781-794. doi: 10.1007/s12275-019-9330-1. Epub 2019 Aug 27.

PMID:
31452043
6.

Estimates of the Prevalence, Intensity and the Number of Workers Exposed to Cigarette Smoking across Occupations and Industries in Korea.

Jung H, Koh DH, Choi S, Park JH, Kim HC, Lee SG, Park D.

J Korean Med Sci. 2019 Aug 12;34(31):e213. doi: 10.3346/jkms.2019.34.e213.

7.

Statin Use in Primary Prevention: A Simple Trial-Based Approach Compared With Guideline-Recommended Risk Algorithms for Selection of Eligible Patients.

Khunti K, Jung H, Dans AL, Held C, Dagenais GR, Yusuf S, Lonn E.

Can J Cardiol. 2019 May;35(5):644-652. doi: 10.1016/j.cjca.2019.03.002. Epub 2019 Mar 19.

PMID:
31030865
8.

Effects of basal insulin glargine and omega-3 on lower limb arterial disease outcome in patients with dysglycaemia: An analysis of the Outcome Reduction with an Initial Glargine INtervention (ORIGIN) trial.

Dagenais GR, Jung H, Bogaty P, Bosch J, Yusuf S, Gerstein HC.

Diabetes Obes Metab. 2019 Jun;21(6):1502-1505. doi: 10.1111/dom.13674. Epub 2019 Mar 20.

PMID:
30785660
9.

The cost implication of primary prevention in the HOPE 3 trial.

Lamy A, Lonn E, Tong W, Swaminathan B, Jung H, Gafni A, Bosch J, Yusuf S.

Eur Heart J Qual Care Clin Outcomes. 2019 Jul 1;5(3):266-271. doi: 10.1093/ehjqcco/qcz001.

PMID:
30657891
10.

Impact of blood pressure lowering, cholesterol lowering and their combination in Asians and non-Asians in those without cardiovascular disease: an analysis of the HOPE 3 study.

Pais P, Jung H, Dans A, Zhu J, Liu L, Kamath D, Bosch J, Lonn E, Yusuf S.

Eur J Prev Cardiol. 2019 May;26(7):681-697. doi: 10.1177/2047487318819019. Epub 2018 Dec 11.

PMID:
30537846
11.

Hypoglycemia and Incident Cognitive Dysfunction: A Post Hoc Analysis From the ORIGIN Trial.

Cukierman-Yaffe T, Bosch J, Jung H, Punthakee Z, Gerstein HC.

Diabetes Care. 2019 Jan;42(1):142-147. doi: 10.2337/dc18-0690. Epub 2018 Nov 13.

PMID:
30425095
12.

Syndecan transmembrane domain modulates intracellular signaling by regulating the oligomeric status of the cytoplasmic domain.

Jang B, Jung H, Hong H, Oh ES.

Cell Signal. 2018 Dec;52:121-126. doi: 10.1016/j.cellsig.2018.09.003. Epub 2018 Sep 6. Review.

PMID:
30195038
13.

Effects of Lipid-Lowering and Antihypertensive Treatments in Addition to Healthy Lifestyles in Primary Prevention: An Analysis of the HOPE-3 Trial.

Dagenais GR, Jung H, Lonn E, Bogaty PM, Dehghan M, Held C, Avezum A, Jansky P, Keltai M, Leiter LA, Lopez-Jaramillo P, Toff WD, Bosch J, Yusuf S.

J Am Heart Assoc. 2018 Jul 22;7(15). pii: e008918. doi: 10.1161/JAHA.118.008918.

14.

Keratinocytes negatively regulate the N-cadherin levels of melanoma cells via contact-mediated calcium regulation.

Chung H, Jung H, Jho EH, Multhaupt HAB, Couchman JR, Oh ES.

Biochem Biophys Res Commun. 2018 Sep 5;503(2):615-620. doi: 10.1016/j.bbrc.2018.06.050. Epub 2018 Jun 14.

PMID:
29902459
15.

Estimation of Lead Exposure Prevalence in Korean Population through Combining Multiple Experts' Judgment based on Objective Data Sources.

Koh DH, Park JH, Lee SG, Kim HC, Choi S, Jung H, Park JO, Park DU.

Ann Work Expo Health. 2018 Feb 13;62(2):210-220. doi: 10.1093/annweh/wxx106.

PMID:
29342235
16.

Effect of Basal Insulin Glargine on First and Recurrent Episodes of Heart Failure Hospitalization: The ORIGIN Trial (Outcome Reduction With Initial Glargine Intervention).

Gerstein HC, Jung H, Rydén L, Diaz R, Gilbert RE, Yusuf S; ORIGIN Investigators.

Circulation. 2018 Jan 2;137(1):88-90. doi: 10.1161/CIRCULATIONAHA.117.030924. No abstract available.

PMID:
29279340
17.

Combining Lead Exposure Measurements and Experts' Judgment Through a Bayesian Framework.

Koh DH, Park JH, Lee SG, Kim HC, Choi S, Jung H, Park DU.

Ann Work Expo Health. 2017 Nov 10;61(9):1054-1075. doi: 10.1093/annweh/wxx072.

PMID:
29136412
18.

D-tyrosine negatively regulates melanin synthesis by competitively inhibiting tyrosinase activity.

Park J, Jung H, Kim K, Lim KM, Kim JY, Jho EH, Oh ES.

Pigment Cell Melanoma Res. 2018 May;31(3):374-383. doi: 10.1111/pcmr.12668. Epub 2017 Nov 27.

PMID:
29121440
19.

Effect of insulin glargine on recreational physical activity and TV viewing: Analysis of the randomised ORIGIN trial.

Yates T, Davies MJ, Jung H, Bosch J, Spinas GA, Sreenan S, Commerford P, Gerstein HC; ORGIN investigators.

Diabetes Res Clin Pract. 2017 Oct;132:137-143. doi: 10.1016/j.diabres.2017.07.035. Epub 2017 Jul 31.

PMID:
28837885
20.

Syndecan-2 cytoplasmic domain up-regulates matrix metalloproteinase-7 expression via the protein kinase Cγ-mediated FAK/ERK signaling pathway in colon cancer.

Jang B, Jung H, Choi S, Lee YH, Lee ST, Oh ES.

J Biol Chem. 2017 Sep 29;292(39):16321-16332. doi: 10.1074/jbc.M117.793752. Epub 2017 Aug 16.

Supplemental Content

Loading ...
Support Center